4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-051679
EVP, Research & CSO sold 3,805 shares at $31.71 ($120,638)
- EVP, Research & CSO acquired 3,805 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…